Actuate Therapeutics IncACTUNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+48.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+48.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$12.52M+93.0%
2024$6.48M+98.6%
2023$3.27M-14.5%
2022$3.82M-